Status:
WITHDRAWN
Dynamic Whole Body PET/ MRI
Lead Sponsor:
British Columbia Cancer Agency
Conditions:
Prostatic Cancer
Eligibility:
MALE
19-99 years
Brief Summary
Prostate cancer is the third most common cause of cancer death in men. Most patients with localized prostate cancer will be cured with surgery or radiation therapy, but up to 35% of patients will have...
Detailed Description
This is a prospective registry study to evaluate the diagnostic utility of 68Ga-HTK03149 DWB PET/MRI to stage patients with high risk prostate cancer who will subsequently under go radical prostatecto...
Eligibility Criteria
Inclusion
- Subjects with biopsy-proven high risk prostate cancer (UCSF/CAPRA score 6 or higher) scheduled for radical prostatectomy.
- Able to not use the washroom for the duration of the dynamic imaging scanning.
- Eastern Cooperative Oncology Group performance status of 2 or less.
- Able to lie supine for the required duration of the scans
Exclusion
- Meet the exclusion criteria for the appropriate standard of care imaging.
- Experience claustrophobia.
- Subjects with severe renal disease or acutely deteriorating renal function (eGRF\<30 mL/min)
- Subjects may not take part in this study if they have a pacemaker, an implanted defibrillator, or certain other implanted electronic or metallic devices, shrapnel, or other metal.
Key Trial Info
Start Date :
August 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2028
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04495959
Start Date
August 1 2025
End Date
September 1 2028
Last Update
January 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BC Cancer
Vancouver, British Columbia, Canada, V5Z 4E6